Events

« Wednesday October 31, 2007 »
Wed
Start: 1:33 pm
End: 1:33 pm

Location: Berlin, Germany

This year’s event follows the highly successful 2005 meeting which took place in Istanbul and attracted 1700 participants.

The ESGO biennial conference attracts the leading clinicians and professionals in the fields of Gynaecology, Obstetrics
and Oncology, and provides a unique forum for networking, the exchange of new initiatives and dialogue on advances in Gynaecological Oncology.

Official Site


Start: 8:00 am
End: 5:00 pm

October 29-November 2, 2007

Location: Babson Executive Conference Center, Wellesley MA
Contact: Sally Aubin
Phone: 781-239-4411
Toll Free Phone: 800-882-EXEC
Fax: 781-239-5266
Email: saubin@babson.edu
Website: http://www3.babson.edu/Bee/programs/biopharma/default.cfm

This program covers the core business and management concepts that are particularly relevant to the biotechnology and pharmaceutical industries, and is essential for those in marketing, research, development, finance, business development, human resources, and manufacturing. Topics such as strategy, leadership, finance and marketing are integrated within an industry-specific context. The program is led by Babson’s world-class faculty as well as industry executives who will share their success (and not so successful) stories. For more information go to: www.babson.edu/bee/biopharma


Start: 8:00 am
End: 5:00 pm

Location: Moscone Center, San Francisco, California

Official Site


Start: 8:00 am
End: 5:00 pm

Location: Hyatt Regency Cambridge, Cambridge, Massachusetts

Non-coding RNAs have recently been recognized as gene-specific regulators and thus are similar in activity to a large number of protein transcription factors that are known to be critical in the transformation of cells to a malignant state. These RNAs can regulate every stage of gene expression: transcription, mRNA stability, and mRNA translation. Cancer cells have genetic and epigenetic changes from their normal counterparts and the role of non-coding RNAs in mediating these differences is beginning to emerge. These changes are a major focus of this conference. In addition, the use of short RNAs to identify novel cancer-relevant genes and to possibly treat cancer will be discussed.

Official Site


Syndicate content